Literature DB >> 20547840

BCL6 promoter interacts with far upstream sequences with greatly enhanced activating histone modifications in germinal center B cells.

Himabindu Ramachandrareddy1, Alyssa Bouska, Yulei Shen, Ming Ji, Angie Rizzino, Wing C Chan, Timothy W McKeithan.   

Abstract

BCL6 encodes a transcriptional repressor that is essential for the germinal center (GC) reaction and important in lymphomagenesis. Although its promoter has been well studied, little is known concerning its possible regulation by more distal elements. To gain such information, we mapped critical histone modifications associated with active transcription within BCL6 as well as far upstream sequences at nucleosomal resolution in B-cell lines and in normal naive and GC B cells. Promoter-associated and intronic CpG islands (CGIs) in BCL6 showed a reciprocal pattern of histone modifications. Gene expression correlated with a paradoxical loss from the intronic CGI of histone H3 lysine-4 trimethylation, normally associated with transcription, suggesting that the intronic CGI may interfere with transcription. In an approximately 110-kb region extending 150-260 kb upstream of BCL6, highly active histone modifications were present only in normal GC B cells and a GC B-cell line; this region overlaps with an alternative breakpoint region for chromosomal translocations and contains a GC-specific noncoding RNA gene. By chromosome conformation capture, we determined that the BCL6 promoter interacts with this distant upstream region. It is likely that transcriptional enhancers in this region activate BCL6 and overcome strong autorepression in GC B cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20547840      PMCID: PMC2900701          DOI: 10.1073/pnas.1004962107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Signatures of the immune response.

Authors:  A L Shaffer; A Rosenwald; E M Hurt; J M Giltnane; L T Lam; O K Pickeral; L M Staudt
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

2.  Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma.

Authors:  Laura Pasqualucci; Anna Migliazza; Katia Basso; Jane Houldsworth; R S K Chaganti; Riccardo Dalla-Favera
Journal:  Blood       Date:  2002-12-19       Impact factor: 22.113

3.  Long-range intrachromosomal interactions in the T helper type 2 cytokine locus.

Authors:  Charalampos G Spilianakis; Richard A Flavell
Journal:  Nat Immunol       Date:  2004-09-19       Impact factor: 25.606

Review 4.  High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays.

Authors:  Matthew J Oberley; Julissa Tsao; Patrick Yau; Peggy J Farnham
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

5.  MatInspector and beyond: promoter analysis based on transcription factor binding sites.

Authors:  K Cartharius; K Frech; K Grote; B Klocke; M Haltmeier; A Klingenhoff; M Frisch; M Bayerlein; T Werner
Journal:  Bioinformatics       Date:  2005-04-28       Impact factor: 6.937

6.  A bivalent chromatin structure marks key developmental genes in embryonic stem cells.

Authors:  Bradley E Bernstein; Tarjei S Mikkelsen; Xiaohui Xie; Michael Kamal; Dana J Huebert; James Cuff; Ben Fry; Alex Meissner; Marius Wernig; Kathrin Plath; Rudolf Jaenisch; Alexandre Wagschal; Robert Feil; Stuart L Schreiber; Eric S Lander
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

7.  The LIM domain protein LPP is a coactivator for the ETS domain transcription factor PEA3.

Authors:  Baoqiang Guo; Rosemary E Sallis; Amanda Greenall; Marleen M R Petit; Erik Jansen; Leonie Young; Wim J M Van de Ven; Andrew D Sharrocks
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

8.  CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line.

Authors:  A Cerutti; H Zan; A Schaffer; L Bergsagel; N Harindranath; E E Max; P Casali
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

9.  Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma.

Authors:  B H Ye; S Chaganti; C C Chang; H Niu; P Corradini; R S Chaganti; R Dalla-Favera
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

10.  Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma.

Authors:  Laura Pasqualucci; Mara Compagno; Jane Houldsworth; Stefano Monti; Adina Grunn; Subhadra V Nandula; Jon C Aster; Vundavally V Murty; Margaret A Shipp; Riccardo Dalla-Favera
Journal:  J Exp Med       Date:  2006-02-20       Impact factor: 14.307

View more
  19 in total

Review 1.  Ontogeny, Genetics, Molecular Biology, and Classification of B- and T-Cell Non-Hodgkin Lymphoma.

Authors:  Russell James Hubbard Ryan; Ryan Alan Wilcox
Journal:  Hematol Oncol Clin North Am       Date:  2019-05-18       Impact factor: 3.722

2.  Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs.

Authors:  Rohit Mathur; Lalit Sehgal; Ondrej Havranek; Stefan Köhrer; Tamer Khashab; Neeraj Jain; Jan A Burger; Sattva S Neelapu; R Eric Davis; Felipe Samaniego
Journal:  Haematologica       Date:  2016-10-14       Impact factor: 9.941

Review 3.  Epigenetic Control of B Cell Development and B-Cell-Related Immune Disorders.

Authors:  Yan Bao; Xuetao Cao
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

4.  Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma.

Authors:  Bjoern Chapuy; Michael R McKeown; Charles Y Lin; Stefano Monti; Margaretha G M Roemer; Jun Qi; Peter B Rahl; Heather H Sun; Kelly T Yeda; John G Doench; Elaine Reichert; Andrew L Kung; Scott J Rodig; Richard A Young; Margaret A Shipp; James E Bradner
Journal:  Cancer Cell       Date:  2013-12-09       Impact factor: 31.743

5.  Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma.

Authors:  Xin Huang; Yulei Shen; Miao Liu; Chengfeng Bi; Chunsun Jiang; Javeed Iqbal; Timothy W McKeithan; Wing C Chan; Shi-Jian Ding; Kai Fu
Journal:  Am J Pathol       Date:  2012-05-18       Impact factor: 4.307

6.  The miR-17-92 microRNA cluster is regulated by multiple mechanisms in B-cell malignancies.

Authors:  Ming Ji; Enyu Rao; Himabindu Ramachandrareddy; Yulei Shen; Chunsun Jiang; Jianxiu Chen; Yiqiao Hu; Angie Rizzino; Wing C Chan; Kai Fu; Timothy W McKeithan
Journal:  Am J Pathol       Date:  2011-07-30       Impact factor: 4.307

7.  Genome-wide association study of B cell non-Hodgkin lymphoma identifies 3q27 as a susceptibility locus in the Chinese population.

Authors:  Dennis E K Tan; Jia Nee Foo; Jin-Xin Bei; Jiang Chang; Roujun Peng; Xiaohui Zheng; Lixuan Wei; Ying Huang; Wei Yen Lim; Juan Li; Qian Cui; Soo Hong Chew; Richard P Ebstein; Ponnudurai Kuperan; Soon Thye Lim; Miriam Tao; Suat Hoon Tan; Alvin Wong; Gee Chuan Wong; Soo Yong Tan; Siok Bian Ng; Yi-Xin Zeng; Chiea Chuen Khor; Dongxin Lin; Adeline L H Seow; Wei-Hua Jia; Jianjun Liu
Journal:  Nat Genet       Date:  2013-06-09       Impact factor: 38.330

8.  Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus.

Authors:  A Batlle-López; M G Cortiguera; M Rosa-Garrido; R Blanco; E del Cerro; V Torrano; S D Wagner; M D Delgado
Journal:  Oncogene       Date:  2013-12-23       Impact factor: 9.867

9.  Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.

Authors:  Russell J H Ryan; Yotam Drier; Holly Whitton; M Joel Cotton; Jasleen Kaur; Robbyn Issner; Shawn Gillespie; Charles B Epstein; Valentina Nardi; Aliyah R Sohani; Ephraim P Hochberg; Bradley E Bernstein
Journal:  Cancer Discov       Date:  2015-07-30       Impact factor: 39.397

10.  Reciprocal occupancy of BCL6 and STAT5 on Growth Hormone target genes: contrasting transcriptional outcomes and promoter-specific roles of p300 and HDAC3.

Authors:  Grace Lin; Christopher R LaPensee; Zhaohui S Qin; Jessica Schwartz
Journal:  Mol Cell Endocrinol       Date:  2014-08-01       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.